A multicenter retrospective cohort study to characterize patients hospitalized with MIS-A and COVID-19 in the United States, 2020-2021.
Michael MelgarJoseph Y AbramsShana Godfred-CatoAmi B ShahAmit GargAndrew StrunkMangala NarasimhanJonathan KoptyevAlexandra NordenDavid MusheyevFahmida RashidRachel TannenbaumRosa M Estrada-Y-MartinBela PatelSiddharth KaranthChad J AchenbachGavin T HallSara M HockneyMatthew CaputoLilian M AbboLaura BeauchampsStephen B MorrisRenzo O CifuentesAnnabelle M de St MauriceDouglas S BellKavitha K PrabakerFernando J Sanz VidorretaEvan BryantDavid K CohenRohith MohanChristopher P LibbySpencer SooHooTristel J DomingoAngela P CampbellErmias D BelayPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2023)
Compared with patients with acute symptomatic COVID-19, adults with MIS-A more often manifest certain symptoms and laboratory findings early during hospitalization. These features may facilitate diagnosis and management.